Joseph Baroldi, EVP, Chief Business Officer at IONIS PHARMACEUTICALS INC (IONS), sold 3,250 shares at $69.37 ($225K) on 2025-10-06, disclosed to the SEC on 2025-10-08.
Scheduled sale ($225k) by EVP, Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $69.37 | 1,625 | $113K | 50.0% |
| 2 | $69.37 | 1,625 | $113K | 50.0% |
| Total | $69.37 avg | 3,250 | $225K | 100% |
| Filing → |
| IONS | SELL | 2026-04-17 | $419K | — | Filing → |
| IONS | SELL | 2026-03-05 | $531K | — | Filing → |
| IONS | SELL | 2026-02-02 | $439K | — | Filing → |